Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 4, 2010, Pages 487-493

  Laharie, David ^a,d   Vergniol, Julien ^d   Bioulac Sage, Paulette ^b,c   Diris, Benoit ^d   Poli, Julie ^d   Foucher, Juliette ^d   Couzigou, Patrice ^d   Drouillard, Jacques ^d   De Lédinghen, Victor ^b,d  

^a Bordeaux Institute of Oncology   (Norway)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Hôpital Pellegrin   (Norway)

^d HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

FibroScan; FibroTest; Liver fibrosis; Magnetic resonance imaging; Nodular regenerative hyperplasia

Indexed keywords

CLIAVIST; FERUCARBOTRAN; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; ELASTOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON TRANSPORT; LIVER BIOPSY; LIVER FIBROSIS; LIVER HYPERPLASIA; MALE; NODULAR REGENERATIVE HYPERPLASIA; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; BIOPSY; CHILD; ELASTICITY IMAGING TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C; HUMANS; HYPERPLASIA; HYPERTENSION, PORTAL; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77949426806     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328334098f     Document Type: Article

References (29)

1. Steiner PE. Nodular regenerative hyperplasia of the liver. Am J Pathol 1959; 35:943-953.
2. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12:60-71.
3. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11:787-797.
4. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44:7-14.
5. Buffet C, Altman C. (Nodular regenerative hyperplasia). Gastroenterol Clin Biol 1994; 18:123-132.
6. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005; 11:627-634; discussion 610-611
7. McCulloch AJ, Morley AR, Wilkinson R, Lesna M. Nodular regenerative hyperplasia of the liver with membranous glomerulonephritis. Postgrad Med J 1981; 57:402-403.
8. Gonzalez-Alegre MT, Guerra-Vales JM, Martinez G, Gutierrez A, Guillen V. Nodular regenerative hyperplasia of the liver and Hodgkin's disease: a case report. Acta Gastroenterol Belg 2004; 67:358-360.
9. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-465.
10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:495-500.
11. Fontaine H, Petitprez K, Roudot-Thoraval F, Trinchet JC. Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol 2007; 31:504-509.
12. De Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008; 32:58-67.
13. Halfon P, Munteanu M, Poynard T. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 2008; 32:22-39.
14. Seiderer J, Zech CJ, Reinisch W, Lukas M, Diebold J, Wrba F, et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 2005; 43:303-309.
15. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29:1705-1713.
16. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
17. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128:343-350.
18. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41:48-54.
19. Van Leeuwen DJ, Balabaud C, Crawford JM, Bioulac-Sage P, Dhillon AP. A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy. Clin Gastroenterol Hepatol 2008; 6: 491-496.
20. Reynolds WJ, Wanless IR. Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: a morphometric study suggesting a role for hepatic arteritis in the pathogenesis. J Rheumatol 1984; 11:838-842.
21. Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 2004; 75: 225-230.
22. Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003; 125:298-303.
23. Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, ReinischW, Laharie D, et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007; 56:1404-1409.
24. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. Aids 2007; 21: 187-192.
25. Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007; 45:675-683.
26. Devarbhavi H, Abraham S, Kamath PS. Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl 2007; 13:1552-1556.
27. Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008; 48:74-82.
28. Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, et al. Transjugular liver biopsy-indications, adequacy, quality of specimens, and complications-a systematic review. J Hepatol 2007; 47:284-294.
29. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134:960-974.